These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 12890715)

  • 1. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
    Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
    Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin.
    Fiorucci S; Distrutti E; de Lima OM; Romano M; Mencarelli A; Barbanti M; Palazzini E; Morelli A; Wallace JL
    FASEB J; 2003 Jun; 17(9):1171-3. PubMed ID: 12709408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
    Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
    Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.
    Fiorucci S; Distrutti E; Mencarelli A; Rizzo G; Lorenzo AR; Baldoni M; Del Soldato P; Morelli A; Wallace JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1174-82. PubMed ID: 14762100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
    Kowal-Bielecka O; Kowal K; Distler O; Rojewska J; Bodzenta-Lukaszyk A; Michel BA; Gay RE; Gay S; Sierakowski S
    Arthritis Rheum; 2005 Dec; 52(12):3783-91. PubMed ID: 16320329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow.
    Ulbrich H; Soehnlein O; Xie X; Eriksson EE; Lindbom L; Albrecht W; Laufer S; Dannhardt G
    Biochem Pharmacol; 2005 Jul; 70(1):30-6. PubMed ID: 15894291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa.
    Fiorucci S; Santucci L; Wallace JL; Sardina M; Romano M; del Soldato P; Morelli A
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10937-41. PubMed ID: 12960371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
    Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
    Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
    Souza MH; de Lima OM; Zamuner SR; Fiorucci S; Wallace JL
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G54-61. PubMed ID: 12637254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A; Serhan CN; Brady HR
    J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.
    Clària J; Serhan CN
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9475-9. PubMed ID: 7568157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition.
    Paredes Y; Massicotte F; Pelletier JP; Martel-Pelletier J; Laufer S; Lajeunesse D
    Arthritis Rheum; 2002 Jul; 46(7):1804-12. PubMed ID: 12124864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.
    Fiorucci S; de Lima OM; Mencarelli A; Palazzetti B; Distrutti E; McKnight W; Dicay M; Ma L; Romano M; Morelli A; Wallace JL
    Gastroenterology; 2002 Nov; 123(5):1598-606. PubMed ID: 12404234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
    Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of arachidonic and eicosapentaenoic Acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures.
    Moreno JJ
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1111-7. PubMed ID: 19776385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD45 antibody enhances lipoxygenase pathway of human naïve mononuclear cells and cyclooxygenase pathway of neutrophils.
    Wu CH; Hsieh SC; Yu HS; Lee KJ; Lu MC; Tsai CY; Yu CL
    Inflamm Res; 2006 Mar; 55(3):92-8. PubMed ID: 16673151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
    Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
    FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.